Double maintains 1 strategies that include RVMD - Revolution Medicines, Inc.
Yahoo
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster presentations will be featured at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, held from April 25 – 30, 2025. The first clinical data in non-small cell lung cancer from the Phase 1 study of zoldonrasib, a RAS(ON) G12D-sele
Yahoo
We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other debt free mid cap stocks. Debt-free mid-cap stocks currently offer compelling investment opportunities, especially in today’s high-interest-rate environment. […]
Yahoo
REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will participate in in two upcoming investor conferences. Details of the company’s participation are as follows: Needham 24th Annual Virtual Healthcare Conference Fireside Chat: Monday,
Yahoo
We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other best mid cap biotech stocks to buy. Is the Biotech Sector Oversaturated? On March 6, Jared Holz, Mizuho health care […]
SeekingAlpha
Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake increases.
Yahoo
We recently published a list of 10 Stocks With At Least $20 Million In Insider Spending Recently. In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against other stocks with at least $20 million in insider spending recently. As the stock market navigates a complex environment shaped […]
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BIV | -<0.01% | $22.26B | 0.03% |
HYD | -0.01% | $3.44B | 0.32% |
IBMP | 0.05% | $513.08M | 0.18% |
IBDS | 0.07% | $2.96B | 0.1% |
GVI | -0.07% | $3.37B | 0.2% |
TBIL | -0.09% | $5.32B | 0.15% |
GTIP | 0.11% | $144.83M | 0.12% |
LTPZ | 0.16% | $731.29M | 0.2% |
BKAG | 0.17% | $1.98B | 0% |
CORN | 0.18% | $51.34M | 0.2% |
IVOL | -0.33% | $479.06M | 1.02% |
CTA | -0.35% | $963.19M | 0.76% |
SPAB | 0.36% | $8.38B | 0.03% |
COM | -0.36% | $241.04M | 0.72% |
LGOV | -0.36% | $658.58M | 0.67% |
HTRB | 0.45% | $2.01B | 0.29% |
YEAR | 0.47% | $1.28B | 0.25% |
FLCB | 0.49% | $2.42B | 0.15% |
GCOR | -0.49% | $356.03M | 0.08% |
SCHZ | 0.50% | $8.58B | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 58.80% | $5.33B | 0.35% |
IBB | 51.03% | $5.92B | 0.45% |
PTH | 50.45% | $110.42M | 0.6% |
GNOM | 49.77% | $53.29M | 0.5% |
PBE | 46.94% | $233.11M | 0.58% |
EFAA | 45.29% | $100.51M | 0% |
IWO | 43.11% | $10.88B | 0.24% |
XPH | 42.97% | $156.75M | 0.35% |
QQA | 42.75% | $172.66M | 0% |
BBH | 42.64% | $368.79M | 0.35% |
ARKG | 42.26% | $977.87M | 0.75% |
PINK | 42.10% | $141.43M | 0.5% |
IWC | 41.55% | $810.14M | 0.6% |
ISCG | 41.27% | $654.50M | 0.06% |
RSPA | 41.18% | $290.25M | 0% |
FBT | 40.47% | $1.08B | 0.56% |
VTWO | 39.55% | $10.91B | 0.07% |
VBK | 39.32% | $17.51B | 0.07% |
IWM | 39.27% | $64.21B | 0.19% |
KJAN | 39.15% | $318.03M | 0.79% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -31.69% | $86.92M | 0.59% |
VIXY | -31.10% | $195.31M | 0.85% |
BTAL | -24.67% | $404.97M | 1.43% |
TPMN | -22.75% | $33.51M | 0.65% |
ULST | -12.50% | $587.03M | 0.2% |
TAXF | -12.39% | $515.52M | 0.29% |
BUXX | -11.97% | $231.44M | 0.25% |
UGA | -11.48% | $88.11M | 0.97% |
DBE | -10.98% | $54.58M | 0.77% |
BNO | -10.54% | $95.40M | 1% |
IBTG | -10.06% | $1.82B | 0.07% |
BSCP | -9.66% | $3.67B | 0.1% |
IBMO | -9.40% | $505.83M | 0.18% |
USO | -9.39% | $1.02B | 0.6% |
USL | -9.15% | $46.60M | 0.85% |
DFNM | -9.15% | $1.50B | 0.17% |
OILK | -9.14% | $66.42M | 0.69% |
XONE | -8.91% | $628.76M | 0.03% |
MMIN | -8.73% | $471.66M | 0.3% |
DBO | -8.09% | $197.54M | 0.77% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -17.93% | $23.69B | +24.42% | 1.08% |
PSQH | -11.73% | $98.27M | -53.36% | 0.00% |
GIS | -10.21% | $32.74B | -14.74% | 3.99% |
INVX | -9.97% | $1.24B | -22.45% | 0.00% |
EQNR | -9.88% | $72.33B | +2.54% | 5.23% |
HPK | -9.64% | $1.60B | -19.87% | 1.27% |
K | -9.29% | $28.48B | +44.57% | 2.75% |
HELE | -9.07% | $1.22B | -53.40% | 0.00% |
EL | -8.39% | $23.74B | -56.59% | 3.02% |
HUSA | -8.31% | $12.08M | -45.38% | 0.00% |
VZ | -8.20% | $190.95B | +7.28% | 5.89% |
CME | -7.85% | $95.61B | +25.13% | 3.98% |
HEES | -7.83% | $3.47B | +50.53% | 1.16% |
LITB | -7.65% | $36.77M | -56.14% | 0.00% |
ED | -7.51% | $39.05B | +22.43% | 3.04% |
CRI | -7.28% | $1.47B | -52.22% | 7.83% |
TSN | -7.20% | $22.28B | +10.30% | 3.10% |
TRVG | -7.15% | $93.53M | +35.76% | 0.00% |
ABEV | -6.87% | $36.65B | -3.72% | 4.69% |
CVI | -6.83% | $1.95B | -47.17% | 5.18% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IDYA | 46.32% | $1.43B | -61.48% | 0.00% |
KYMR | 45.72% | $1.78B | -30.57% | 0.00% |
CRNX | 44.31% | $3.12B | -27.92% | 0.00% |
RYTM | 43.65% | $3.35B | +24.11% | 0.00% |
DYN | 43.19% | $1.18B | -62.64% | 0.00% |
RCKT | 41.82% | $711.22M | -75.04% | 0.00% |
RNA | 41.43% | $3.55B | +11.82% | 0.00% |
RARE | 41.22% | $3.35B | -22.91% | 0.00% |
DNLI | 41.18% | $1.97B | -33.88% | 0.00% |
KRYS | 40.60% | $5.19B | +2.40% | 0.00% |
IMNM | 40.34% | $585.18M | -69.56% | 0.00% |
CLDX | 39.99% | $1.20B | -56.41% | 0.00% |
DAWN | 39.55% | $803.75M | -50.93% | 0.00% |
ELVN | 39.20% | $964.41M | +4.13% | 0.00% |
SYRE | 37.56% | $972.25M | -56.39% | 0.00% |
NRIX | 37.33% | $901.54M | -18.52% | 0.00% |
AGIO | 37.11% | $1.68B | +1.52% | 0.00% |
ZYME | 36.91% | $835.45M | +20.55% | 0.00% |
IONS | 36.77% | $4.80B | -31.34% | 0.00% |
ACLX | 36.64% | $3.60B | -2.06% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
REYN | 0.01% | $5.01B | -17.55% | 3.85% |
POAI | -0.01% | $10.96M | -33.04% | 0.00% |
TAP | 0.02% | $12.33B | -9.59% | 2.93% |
SOL | -0.04% | $80.57M | -32.91% | 0.00% |
CCI | -0.04% | $45.38B | -0.03% | 5.99% |
MKC | -0.09% | $22.07B | +7.43% | 2.07% |
LMT | -0.12% | $105.15B | -1.34% | 2.88% |
IMNN | 0.12% | $15.35M | -45.60% | 0.00% |
EC | 0.13% | $21.46B | -13.79% | 14.98% |
STG | 0.16% | $28.45M | -43.90% | 0.00% |
CORT | -0.16% | $12.05B | +343.75% | 0.00% |
PDCO | 0.17% | $2.76B | +15.40% | 2.50% |
SPTN | -0.20% | $684.07M | +2.07% | 4.31% |
NTZ | 0.24% | $54.08M | -21.44% | 0.00% |
CQP | -0.25% | $31.97B | +33.68% | 4.87% |
IDXX | 0.26% | $34.03B | -21.12% | 0.00% |
AQB | -0.26% | $2.67M | -65.90% | 0.00% |
CCRN | -0.27% | $488.58M | -19.25% | 0.00% |
HMST | -0.32% | $222.13M | -19.64% | 0.00% |
TKC | -0.32% | $5.42B | +21.01% | 3.29% |
Current Value
$35.351 Year Return
Current Value
$35.351 Year Return